This just touched the support line an are still in uptrend, there is rumours about major pharma partnership an if we get any news about that this will skyrocket the ipo price was 15$ an now around 3,5$ they have some producs ready to launch but wayting for embargo to lift an publican in medical journal. My biggest position in my portfolio an adding as much i can when it has some dips, i believe this will be between 5-7,5$ before we reach jan. 2022. Gl everyone dont buy this on my recomendation but do your own dd better loose money on you self than my recomendation :)